Clinical Updates on Assisted Reproductive Technologies

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Obstetrics & Gynecology".

Deadline for manuscript submissions: 25 April 2024 | Viewed by 1086

Special Issue Editor

IVIRMA Rome, 00197 Rome, Italy
Interests: adenomyosis; ovarian reactivation; endometrial PRP

Special Issue Information

Dear Colleagues,

The rate of infertility is rising worldwide, with the latest data from a recent report, published by the WHO earlier in 2023, stating that the lifetime prevalence of infertility in the adult population is 17.5%, which roughly equates to around 1 in 6 people globally having experienced infertility at some stage in their lives. The rapidly evolving advancements in the science and expertise dedicated to assisted reproductive technologies should aim to target the challenges that this data brings about, especially with the increasing trend in the modern world of people seeking fertility at an older age. Updates in individualizing ovarian stimulation treatment protocols, gamete donation programs, treatment of endometriosis and advancements in the management of uterine factors including adenomyosis, are classic examples, whilst newer concepts include the paternal contribution and the role of epigenetics towards embryo development, and ovarian rejuvenation techniques. The scope of this Special Issue is to provide a homogeneity of data and updated evidence which can be used by clinicians and laboratory scientists worldwide to improve the clinical reproductive outcomes of an increasingly infertile population. Researchers in these fields of reproductive medicine are encouraged to submit original articles or reviews to this Special Issue (excluding case reports and short reviews).

Dr. Mauro Cozzolino
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • adenomyosis
  • endometriosis
  • egg donation
  • individualized ovarian stimulation protocols
  • ovarian rejuvenation
  • male factor infertility

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 744 KiB  
Review
Oocyte Cryopreservation in Women with Ovarian Endometriosis
J. Clin. Med. 2023, 12(21), 6767; https://doi.org/10.3390/jcm12216767 - 26 Oct 2023
Cited by 1 | Viewed by 928
Abstract
Ovarian endometriosis is a gynecological condition that is closely associated with infertility—from its pathogenesis to treatment modalities, this condition presents a challenge both for patients and clinicians alike when seeking conception, due to low AMH levels, peritoneal inflammation, and the inadvertent removal of [...] Read more.
Ovarian endometriosis is a gynecological condition that is closely associated with infertility—from its pathogenesis to treatment modalities, this condition presents a challenge both for patients and clinicians alike when seeking conception, due to low AMH levels, peritoneal inflammation, and the inadvertent removal of healthy ovarian parenchyma at surgery. In fact, around half of endometriosis patients seeking fertility require tertiary-level assisted reproduction techniques to achieve a live birth. Oocyte cryopreservation, a procedure initially designed for oncology patients, has emerged over recent years as a very promising treatment strategy for patients who have been diagnosed with ovarian endometriosis in order to preserve their fertility and obtain a live birth at a later stage in their lives. Counseling patients about oocyte preservation techniques at an early stage in the diagnosis, ideally before the age of 35 and especially prior to any surgical treatment, provides an excellent opportunity to discuss future fertility and the benefits associated with oocyte cryopreservation. Full article
(This article belongs to the Special Issue Clinical Updates on Assisted Reproductive Technologies)
Show Figures

Figure 1

Back to TopTop